IL10 and Hyperglycemia: Concomitantly, NGF triggers an anti-inflammatory response in surface inducing production of IL-1 receptor antagonist and IL-10 and dampens NF-κB activation, thereby reducing hyperglycemia-driven corneal inflammation [68].